Beruflich Dokumente
Kultur Dokumente
GE Healthcare
Objectives
To promote medical device industry in Malaysia To create awareness among stakeholders on policy and regulatory requirements To identify and overcome issues and challenges in medical industry
1/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Agenda
Global Harmonisation Task Force - Who is GHTF? - Current regulations in GHTF members - Understand recipient / importing market requirements Harmonized Regulatory Approach - What is harmonization?
Agenda
Identify & Overcome Issues and Challenges
Tools Common Dossiers - Common Submission Dossier Template (CSDT) - Global / 3rd party manufacturing sites - Quality management systems (QMS) Tools Grouping of Devices - Systems, Groups, Families, Spare Parts, Expendables - Registration of devices - Import and local supply of medical devices
2/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
GHTF Members
EUROPEAN UNION
Active Implantable Medical Directive 1990 Medical Devices Directive 1993 In-Vitro Diagnostics Directive 1998
OTHERS
Therapeutic Goods Act 1989 (Australia) Therapeutic Goods (Medical Devices) Regulations 2002 (Australia) Medical Device Regulations 1998 (Canada) Pharmaceutical Affairs Law 1948,1960,1979,2002
All Rights Reserved 2007 Health Sciences Authority
3/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
USA
4/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
Premarket Requirements
Classification determines type of premarket submission required for market clearance Class I and II devices typically require premarket notification (510k), unless exempt by regulation Class III devices require submission of premarket approval (PMA)
USA
Premarket Requirements
Class I
General controls sufficient to provide reasonable assurance of safety and effectiveness General controls: Establishment registration Medical device listing Labelling requirements Premarket notification (510k) submission (unless exempted by regulations) Manufacture under GMP requirements (Note: All classes are subject to general controls)
All Rights Reserved 2007 Health Sciences Authority
10
5/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
Premarket Requirements
Class II
General controls insufficient to provide reasonable assurance of safety and effectiveness. In addition to general controls, special controls are necessary
Special controls: Special labelling requirements Mandatory performance standards Post market surveillance
11
USA
Premarket requirements
Class III
General controls and special controls insufficient to provide reasonable assurance of safety and effectiveness
Premarket approval (PMA) is required : scientific review to ensure safety and effectiveness
12
6/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
Premarket requirements
Premarket notification (510k)
Premarket application to demonstrate that device is as safe and effective i.e. substantially equivalent to a legally marketed device (i.e. predicate device) A device is substantially equivalent to a predicate device if it Has the same intended use and technological characteristics as the predicate device OR Has the same intended use as the predicate device and different technological characteristics that do not raise new questions of safety and effectiveness
13
USA
Premarket requirements
Premarket Approval (PMA)
Scientific review to evaluate the safety and effectiveness of Class III devices. Sufficient valid scientific evidence to assure that the device is safe and effective for its intended use must be submitted An approved PMA is, in effect, a private license granting the applicant permission to market the device
14
7/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
Premarket requirements
Premarket Approval (PMA)
Review of a PMA is a 4 step review process consisting of: Administrative and limited scientific review by FDA staff to determine completeness (filing review) In depth scientific and regulatory review by appropriate FDA scientific and compliance personnel (in depth review) Review and recommendation by the appropriate advisory committee (panel review) An FDA good manufacturing practices (GMP) inspection
15
USA
16
8/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
USA
Postmarket Requirements
Requirements are set out in the Safe Medical Devices Act and FDA Modernisation Act: Manufacturers must submit medical device reports for device which caused death or serious injury, or, if the malfunction were to recur, would have cause death or serious injury User facilities must report device related deaths and serious injuries and submit a summary of all reports to FDA on an annual basis Manufacturers must have in place distribution records and other methods for tracking permanent implants or life sustaining/supporting devices used outside a facility Manufacturers and importers must report to FDA any removals and corrections of a device from the market
17
European Union
18
9/ GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
EU
Regulatory Framework
Medical Devices are regulated by three main Directives: Council Directive 90/385/EEC on Active Implantable Medical Devices (AIMDD), 1990 Council Directive 93/42/EEC on Medical Devices (MDD), 1992 Council Directive 98/79/EC on In Vitro Diagnostic Medical Devices (IVDMD), 1998
19
EU
20
10 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
EU
Premarket Requirements
Each member state appoints a competent authority (CA) to act as the States regulator and the CA in turn appoints notified bodies (NB) to implement the requirements of the directives (certification of CE marking and quality systems) NBs are typically test laboratories and quality systems organizations
21
EU
Premarket Requirements
Directives define the essential requirements that devices have to meet when they are put on the market or put into service (Annex I) Directives contain a number of conformity assessment procedures, which depend on the type of products and type of risks involved (Annex II VII) Except for low risk devices, these procedures always involve independent bodies, so-called Notified Bodies, designated and monitored by national authorities. In a number of cases, authorities act themselves as Notified Bodies Compliance with harmonized European standards will provide a presumption of conformity with the relevant essential requirements Devices that meet the essential requirements and have undergone the appropriate conformity assessment procedures will be CE marked. The CE denotes a formal statement by the manufacturer of compliance with the Directives requirements.
All Rights Reserved 2007 Health Sciences Authority
22
11 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
23
EU
24
12 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
EU
Postmarket Requirements
Manufacturer is required to establish and maintain a system for reporting and acting upon incidents affecting health and safety of patient or user
25
Canada
26
13 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Canada
27
Canada
Premarket requirements
All classes of devices must meet the following requirements: Manufacturers must ensure that device meets safety and effectiveness requirements in the Regulations and maintain objective evidence as proof. (Compliance with the safety and effectiveness requirements can be demonstrated through the use of Health Canada recognised standards.) Any person who imports or sells a medical device and any manufacturer who distributes directly to users must obtain an establishment licence
28
14 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Canada
Premarket requirements
In addition, Class II, III or IV devices: Device licence required prior to import and sales in Canada Class III and IV devices require scientific and medical review of submitted evidence of safety and effectiveness Class II devices only require quality system audit Amount of information required to be submitted to obtain a device licence increases as the risk class increases. Class I devices: Exempt from device licensing requirements
All Rights Reserved 2007 Health Sciences Authority
29
Canada
15 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Canada
Postmarket requirements
Postmarket requirements apply to all classes of devices: Maintaining distribution records of each device Mandatory problem reporting Recall Implant registration
31
Australia
32
16 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Australia
33
Australia
Premarket Requirements
The classification of a medical device determines the conformity assessment procedure(s) a manufacturer can choose to ensure that the device is adequately assessed to conform to the essential principles of safety and performance defined in Australian legislation Higher class devices undergo a more stringent form of conformity assessment than lower class devices Depending on the procedure chosen, assessment of the final design, the controls implemented for production and the manufacturers courses of action may have to be assessed by the TGA or another appropriate conformity assessment body.
34
17 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
35
Australia
Premarket requirements
The following kind of medical device manufacturers are required under Australian Legislation to obtain a Conformity Assessment Certificate issued by TGA before the medical device can be included in the ARTG: All Australian manufacturers Any manufacturer who manufactures medical devices containing materials derived from animal, microbial or recombinant origin. Any manufacturer who manufactures medical devices containing medicinal substances Any manufacturer who manufactures medical devices containing blood plasma derivatives.
36
18 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Australia
Premarket Requirements
Overseas manufacturers not belonging to one of the categories described above and who hold current EC certification issued by an EU Notified Body under the EU Medical Devices Directive 93/42/EEC (MDD) or the EU Active Implantable Medical Devices Directive 90/385/EEC (AIMDD) are allowed, under certain conditions, to use EC certificates to support an application for inclusion in the ARTG. These manufacturers do not require a Conformity Assessment Certificate to be issued by the TGA prior to making an application to include the device in the ARTG.
37
Australia
38
19 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Australia
Postmarket Requirements
Vigilance System - Mandatory reporting system for adverse events involving all medical devices. Based on recommendations of GHTF Sponsors are required to report any problem to the manufacturer of the device. Manufacturers are required to report the problem to the TGA. The Vigilance System comprises: penalties and time frames recall and seizure provisions voluntary reporting provisions for medical device users international information exchange between conformity assessment bodies information exchange between inter governmental agencies within Australia (such as Health Care Complaints Commission and coronial inquests)
All Rights Reserved 2007 Health Sciences Authority
39
40
20 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonized Approach
Harmonization
Quality Management System (QMS) Post-market Surveillance Technical Documentation Declaration of Conformity Registration of manufacturers, distributors and their devices
21 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonization is: A process of sharing; Agreeing (and disagreeing) on best practices within regulatory control regime for MD; and Achieving a least burdensome regulatory pathway to market(s) as a desired outcome.
(current)
Medical device means any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material or other similar or related article:a) intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the specific purpose(s) of: diagnosis, prevention, monitoring, treatment or alleviation of disease, diagnosis, monitoring, treatment, alleviation of or compensation for an injury, investigation, replacement, modification, or support of the anatomy or of a physiological process, supporting or sustaining life, control of conception, disinfection of medical devices, providing information for medical or diagnostic purposes by means of in vitro examination of specimens derived from the human body;
Reference: GHTF/SG1/N29R16:2005, Information Document Concerning the Definition of the Term "Medical Device"
44 / GE Title or job number / 11/23/2011
4 4
22 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
(current)
Medical device means any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material or other similar or related article:and b) which does not achieve its primary intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its intended function by such means. The definition of a device for in-vitro examination includes, for example, reagents, calibrators, sample collection and storage devices, control materials, and related instruments or apparatus. The information provided by such an in-vitro diagnostic device may be for diagnostic, monitoring or compatibility purposes.
Reference: GHTF/SG1/N29R16:2005, Information Document Concerning the Definition of the Term "Medical Device"
45 / GE Title or job number / 11/23/2011
4 5
23 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Manufacturer Information
24 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Finland
Monitor AB12 Monitor B82
Mexico
China
Accessories manufacturing
Mexico
Monitor V2B8
25 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
26 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
EC Certificate
EC Certificate Approval full Quality Assurance System Annex II section 3 Directive 93/42/EEC concerning medical devices Manufacturer GE Hangwei Medical Systems Device category CT Scanners MRI systems G-Med certifies that, on the basis of the results contained in the file referenced J018084-R, the quality system for design, manufacturing, and final inspection of medical devices listed here above complies with the requirements of the Directive 93/42/EEC, annex II section 3.
27 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonization (revisit)
Quality Management System (QMS) Post-market Surveillance o Technical Documentation o Declaration of Conformity o Registration of manufacturers, distributors and their devices
28 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
29 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Ensuring Competency
Conformity Assessment Bodies Manufacturers Distributors Hospitals, clinics, retail
30 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonization (revisit)
Quality Management System (QMS) Post-market Surveillance o Technical Documentation o Declaration of Conformity o Registration of manufacturers, distributors and their devices
Identify & Overcome Issues & Challenges Tools Grouping of Medical Devices
31 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Microbiology Physical Medicine Ob / Gyn Ophthalmic Immunology Hematology Ear Nose & Throat Toxicology Pathology
Patient Monitors
ED
Supplies & Accessories
Cath/EP Lab
OR
ICU
Telemetry
64 / GE Title or job number / 11/23/2011
32 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
33 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
X-Ray tube
Source: http://www.hcstarck.com/
34 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Finland
Monitor AB12 Monitor B82
Mexico
China
Accessories manufacturing
Mexico
Monitor V2B8
Stakeholders
Hospitals / Clinics / Users
People
Manufacturers
35 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonization (revisit)
Quality Management System (QMS) Post-market Surveillance Technical Documentation
- review sample device label
36 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Harmonization (revisit)
Implement MD regulatory system Declaration of Conformity (legal attestation) Registration of manufacturers, distributors and their devices (MD
regulatory control regime)
Objectives
To promote medical device industry in Malaysia To create awareness among stakeholders on policy and regulatory requirements To identify and overcome issues and challenges in medical industry
37 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Import of Medical Devices Harmonized System (HS) Codes mapped to medical device registrations / product codes Licensed entities permitted to import devices (incl. accessories/spare parts) they have registered
38 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Conclusion
Global Harmonization Task Force - What is GHTF & their current regulations? Harmonization - What is / what is not harmonization? Tools of Harmonization Common Dossiers, Grouping - Tools to be used for registration - Tools to be used for designing a regulatory framework that is least burdensome
Conclusion
Tools of Harmonization Common Dossiers, Grouping - Use of international Standards / local standards) - Outsourced / 3rd party manufacturing sites - Clarity in grouping rules (affects registration fees) - Grouping affects multi-country use of CSDT - Inclusion of accessories codes into CSDT (affects Import and supply of accessories) - Import and supply of spare parts / expendables (affects local supply)
39 / GE /
Presentation at Malaysia Medical Device Regulatory Conference Langkawi, Malaysia - 24 Nov 2011
Conclusion
Recommendations
- Aware of need to map against other regulatory elements and guidance documents for setting up a harmonized regulatory framework (e.g. registration of manufacturers and listing of
medical device, definition of MD, classification of MD, definition of manufacturers, authorized representatives)
Thank You
40 / GE /